(b) DISSEMINATION
OF INFORMATION.—The Sec-
retary is encouraged to disseminate information under 
subsection (a) through a cooperative agreement with a na-
tional nonprofit entity with expertise in pulmonary hyper-
tension. 
(c) REPORT TO CONGRESS.—Not later than Sep-
tember 30, 2009, the Secretary shall report to the Com-
mittee on Energy and Commerce of the House of Rep-
resentatives, the Committee on Health, Education, Labor, 
and Pensions of the Senate, and the Committee on Appro-
priations of the House of Representatives and the Senate 
on the status of activities under this section. 
(d) AUTHORIZATION OF APPROPRIATIONS.—For the 
purpose of carrying out this section, there is authorized 
to be appropriated $2,500,000 for each of fiscal years 
2009, 2010, and 2011. 
SEC. 202. PROMOTING AWARENESS AMONG HEALTH CARE 
PROFESSIONALS. 
(a) IN GENERAL.—The Secretary, acting through the 
Administrator of the Health Resources and Services Ad-
ministration and the Director of the Centers for Disease 
Control and Prevention, shall carry out an educational 
campaign to increase awareness of pulmonary hyper-
tension among health care providers. Print, video, and 
VerDate Aug 31 2005 
06:30 Jul 23, 2008
Jkt 069200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H6568.IH
H6568
erowe on PROD1PC71 with BILLS
Web-based materials distributed under this program may 
include information on— 
(1) the symptoms of pulmonary hypertension; 
(2) the importance of early diagnosis; 
(3) current diagnostic criteria; and 
(4) Food and Drug Administration-approved 
therapies for the disease. 
(b) TARGETED HEALTH CARE PROVIDERS.—Health 
care providers targeted through the campaign under sub-
section (a) shall include, but not be limited to, cardiolo-
gists, pulmonologists, rheumatologists, primary care phy-
sicians, pediatricians, and nurse practitioners 
(c) DISSEMINATION
OF INFORMATION.—The Sec-
retary is encouraged to disseminate information under 
subsection (a) through a cooperative agreement with a na-
tional nonprofit entity with expertise in pulmonary hyper-
tension. 
(d) REPORT TO CONGRESS.—Not later than Sep-
tember 30, 2009, the Secretary shall report to the Com-
mittee on Energy and Commerce of the House of Rep-
resentatives, the Committee on Health, Education, Labor, 
and Pensions of the Senate, and the Committee on Appro-
priations of the House of Representatives and the Senate 
on the status of activities under this section. 
VerDate Aug 31 2005 
06:30 Jul 23, 2008
Jkt 069200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H6568.IH
H6568
erowe on PROD1PC71 with BILLS
(e) AUTHORIZATION OF APPROPRIATIONS.—For the 
purpose of carrying out this section, there is authorized 
to be appropriated $2,500,000 for each of fiscal years 
2009, 2010, and 2011. 
TITLE 
III—GOVERNMENT 
AC-
COUNTABILITY 
OFFICE 
STUDY 
SEC. 301. STUDY ON MEDICARE AND MEDICAID COVERAGE 
STANDARDS 
FOR 
PULMONARY 
HYPER-
TENSION THERAPIES. 
(a) IN GENERAL.—The Comptroller General of the 
United States shall conduct a study on the coverage stand-
ards that, under the programs under titles XVIII and XIX 
of the Social Security Act (commonly known as Medicare 
and Medicaid, respectively), apply to patients with pul-
monary hypertension. The study shall detail Medicare and 
Medicaid coverage standards for all therapies approved by 
the Food and Drug Administration for the treatment of 
pulmonary hypertension. 
(b) CONTENT.—The study under subsection (a) shall 
take into account the appropriate outpatient or home 
health care delivery settings. 
(c) REPORT.—Not later than September 30, 2009, 
the Comptroller General shall submit to the Congress a 
VerDate Aug 31 2005 
06:30 Jul 23, 2008
Jkt 069200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H6568.IH
H6568
erowe on PROD1PC71 with BILLS
report describing the findings of the study under sub-
section (a). 
Æ 
VerDate Aug 31 2005 
06:30 Jul 23, 2008
Jkt 069200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6301
E:\BILLS\H6568.IH
H6568
erowe on PROD1PC71 with BILLS